Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in Transfusion

Retrieve available abstracts of 139 articles:
HTML format

Single Articles

    June 2024
  1. YEE MEM, Covington ML, Zerra PE, McCoy JW, et al
    Survival of transfused red blood cells from a donor with alpha-thalassemia trait in a recipient with sickle cell disease.
    Transfusion. 2024;64:1109-1115.
    PubMed     Abstract available

  2. LINSTROM M, Musekwa E, Nell EM, de Waard L, et al
    The influence of hematological profiles on the transfusion management and mortality risk of mothers presenting to the obstetric unit of a South African tertiary medical facility.
    Transfusion. 2024;64:986-997.
    PubMed     Abstract available

    May 2024
  3. RAMSEY G, Barriteau CM
    Estimating the serological underrecognition of patients with weak or partial RHD variants.
    Transfusion. 2024;64:920-928.
    PubMed     Abstract available

  4. WERNEIWSKI K, Gehrie EA
    Development of an interactive mapping tool to estimate where resources for people living with sickle cell disease may be needed most.
    Transfusion. 2024;64:772-774.

  5. YEE MEM, Zerra PE, McCoy JW, Covington ML, et al
    Post-transfusion biotin-labeled red blood cell survival studies in pediatric sickle cell disease with antibodies of uncertain significance.
    Transfusion. 2024;64:800-807.
    PubMed     Abstract available

    April 2024
  6. JAVANBAKHT A, Schneider TM, Hendrickson JE
    Red blood cell alloimmunization in patients on extracorporeal membrane oxygenation.
    Transfusion. 2024;64:761-762.

  7. ROGERS K, Alsawas M, Chapman J, Schlueter AJ, et al
    Using the daily rate of rise in hemoglobin S to manage RBC depletion/exchange treatment in sickle cell disease.
    Transfusion. 2024;64:685-692.
    PubMed     Abstract available

  8. LEIVA-TORRES GA, Cigna M, Constanzo-Yanez J, St-Louis M, et al
    Transfusing children with sickle cell disease using blood group genotyping when the pool of Black donors is limited.
    Transfusion. 2024;64:716-726.
    PubMed     Abstract available

  9. CHASE RC, Koop AH, Shaikh M, Imperial RJ, et al
    Successful treatment of severe passenger lymphocyte syndrome with efgartigimod synergy.
    Transfusion. 2024;64:755-760.
    PubMed     Abstract available

  10. WANG L, Rochon ER, Gingras S, Zuchelkowski BE, et al
    Functional effects of an African glucose-6-phosphate dehydrogenase (G6PD) polymorphism (Val68Met) on red blood cell hemolytic propensity and post-transfusion recovery.
    Transfusion. 2024;64:615-626.
    PubMed     Abstract available

    March 2024
  11. JORGENSEN CC, Michelsen C, Petersen T, Kehlet H, et al
    Preoperative hemoglobin thresholds for increased risk of "medical" complications in fast-track total hip and knee arthroplasty, a secondary analysis of a machine-learning algorithm.
    Transfusion. 2024;64:438-442.
    PubMed     Abstract available

  12. ISRAELYAN N, Vege S, Friedman DF, Zhang Z, et al
    RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA.
    Transfusion. 2024;64:526-535.
    PubMed     Abstract available

    February 2024
  13. CAO J, Lu S, Luo D, Pei R, et al
    Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab.
    Transfusion. 2024 Feb 13. doi: 10.1111/trf.17743.
    PubMed     Abstract available

  14. PETERMANN S, Mayer V, Carbol A, Opitz A, et al
    Compound heterozygosity induces a rare Gerbich-negative phenotype in an immunized blood donor.
    Transfusion. 2024;64:406-411.
    PubMed     Abstract available

  15. MO A, Wood E, Shortt J, Charlton A, et al
    Rethinking the transfusion pathway in myelodysplastic syndromes: Study protocol for a novel randomized feasibility n-of-1 trial of weekly-interval red cell transfusion in myelodysplastic syndromes.
    Transfusion. 2024;64:236-247.
    PubMed     Abstract available

    January 2024
  16. CIGNA M, Leiva-Torres GA, Baillargeon N, Yanez JC, et al
    Management of a patient with sickle cell disease and multiple red blood cell alloantibodies in preparation for a hematopoietic stem cell transplantation.
    Transfusion. 2024 Jan 11. doi: 10.1111/trf.17715.
    PubMed     Abstract available

  17. BRANCAMP R, Hughes CE, Dar A, Polic A, et al
    Homozygous SPTA1-associated hereditary pyropoikilocytosis presenting as hydrops fetalis.
    Transfusion. 2024;64:189-193.
    PubMed     Abstract available

  18. LIPMAN T, Bienz MN, Pendergrast J, Cserti-Gazdewich C, et al
    Unexpected difficulty in performance of a monocyte monolayer assay when using RBCs from a patient with sickle cell disease.
    Transfusion. 2024;64:4-5.

  19. STEVENS-HERNANDEZ CJ, Gyorffy G, Meli A, New HV, et al
    Vesiculation in irradiated and cation-leaky-stored red blood cells.
    Transfusion. 2024;64:150-161.
    PubMed     Abstract available

    December 2023
  20. CALJE E, Oyston C, Wang Z, Bloomfield F, et al
    The fatigue after infusion or transfusion pilot trial and feasibility study: A three-armed randomized pilot trial of intravenous iron and blood transfusion for the treatment of postpartum anemia.
    Transfusion. 2023 Dec 27. doi: 10.1111/trf.17621.
    PubMed     Abstract available

  21. MERCURE-CORRIVEAU N, Crowe EP, Vozniak S, Feng X, et al
    Euvolemic automated transfusion to treat severe anemia in sickle cell disease patients at risk of circulatory overload.
    Transfusion. 2023 Dec 8. doi: 10.1111/trf.17613.
    PubMed     Abstract available

  22. CROWE EP, Hasan R, Saifee NH, Bakhtary S, et al
    How do we perform intrauterine transfusions?
    Transfusion. 2023;63:2214-2224.
    PubMed     Abstract available

  23. KAYANO SS, Santana PV, Colella R, Colella MP, et al
    Lower platelet count and metastatic tumor are associated with increased risk of spontaneous bleeding in critically ill patients with cancer: An observational study.
    Transfusion. 2023;63:2311-2320.
    PubMed     Abstract available

    November 2023
  24. RYDEN J, Clements M, Wikman A, Hellstrom-Lindberg E, et al
    Red blood cell alloimmunization in myelodysplastic syndromes: Associations with sex, DAT-positivity, and increased transfusion needs.
    Transfusion. 2023;63:2040-2051.
    PubMed     Abstract available

    October 2023
  25. GOLLAMUDI J, Dasgupta SK, Thiagarajan P
    Erythrophagocytosis in autoimmune immunoglobulin A-mediated hemolysis.
    Transfusion. 2023;63:1978-1982.
    PubMed     Abstract available

    September 2023
  26. ABELS E, Jacobs JW, Prior D, Willets LC, et al
    Passive transfer of alloantibodies through breast milk as a mediator of hemolytic anemia.
    Transfusion. 2023 Sep 14. doi: 10.1111/trf.17548.
    PubMed     Abstract available

    August 2023
  27. SOTOLONGO G, Poisson JL
    Increased red blood cell alloimmunization rates in transfused aplastic anemia and myelofibrosis patients.
    Transfusion. 2023 Aug 30. doi: 10.1111/trf.17529.
    PubMed     Abstract available

  28. LASOCKI S, Delahaye D, Fuks D, Savoie PH, et al
    Management of perioperative iron deficiency anemia as part of patient blood management in France: A budget impact model-based analysis based on real world data.
    Transfusion. 2023 Aug 23. doi: 10.1111/trf.17495.
    PubMed     Abstract available

  29. ARYA S, Xiang T, Tang GH, Pavenski K, et al
    Including the patient in patient blood management: Development and assessment of an educational animation tool.
    Transfusion. 2023;63:1488-1494.
    PubMed     Abstract available

    July 2023
  30. ABDELHAY A, Mahmoud AA, Ammari O, Dalbah R, et al
    Outcomes of therapeutic plasma exchange in severe autoimmune hemolytic anemia hospitalizations: An analysis of the National Inpatient Sample.
    Transfusion. 2023 Jul 3. doi: 10.1111/trf.17445.
    PubMed     Abstract available

  31. WEBB CB, Yates SG, Sarode R, Kim J, et al
    Plasma exchange-A useful adjunct therapy to red cell exchange in patients with sickle cell disease and multiorgan dysfunction.
    Transfusion. 2023;63:1384-1390.
    PubMed     Abstract available

  32. HAW J, Walrond J, Jayachandran J, Dordunoo D, et al
    Sickle cell disease and the need for blood: Barriers to donation for African, Caribbean, and Black young adults in Canada.
    Transfusion. 2023;63:1324-1332.
    PubMed     Abstract available

    June 2023
  33. DESIMONE RA, Plimier C, Goel R, Hendrickson JE, et al
    Associations of donor, component, and recipient factors on hemoglobin increments following red blood cell transfusion in very low birth weight infants.
    Transfusion. 2023 Jun 30. doi: 10.1111/trf.17468.
    PubMed     Abstract available

  34. WALL E, Bolster L
    Complications of red cell exchange for anemia management in patients with transfusion-dependent thalassemia.
    Transfusion. 2023 Jun 15. doi: 10.1111/trf.17419.
    PubMed     Abstract available

  35. STEFFEN KM, Spinella PC, Holdsworth LM, Ford M, et al
    Factors influencing pediatric transfusion: A complex decision impacting quality of care.
    Transfusion. 2023;63:1151-1160.
    PubMed     Abstract available

    May 2023
  36. CARTER PW, Dunham AJ
    Modeling hemoglobin levels of patients chronically transfused with red blood cells.
    Transfusion. 2023;63:952-959.
    PubMed     Abstract available

  37. SHAULOV A, Rund D, Filon D, Nachmias B, et al
    Successful treatment with plasma exchange in life-threatening hyperhemolytic syndrome unrelated to sickle cell disease.
    Transfusion. 2023;63:1100-1106.
    PubMed     Abstract available

  38. YAZER MH, Spinella PC, Sperry J, Triulzi DJ, et al
    Timing of RhD-positive red blood cell administration is associated with D-alloimmunization in injured patients.
    Transfusion. 2023;63 Suppl 3:S54-S59.
    PubMed     Abstract available

    April 2023
  39. GOEL R, Roubinian NH, Bembea MM
    Disentangling the causes of RBC loss and anemia in ECMO patients: Some questions answered?
    Transfusion. 2023 Apr 10. doi: 10.1111/trf.17347.

    March 2023
  40. JUTRAS C, Sauthier M, Tucci M, Trottier H, et al
    Prevalence and determinants of anemia at discharge in pediatric intensive care survivors.
    Transfusion. 2023 Mar 12. doi: 10.1111/trf.17309.
    PubMed     Abstract available

  41. COSTA V, Mercure-Corriveau N, Gourneau J, Tobian AAR, et al
    Transfusion-transmitted babesiosis in a patient with sickle cell disease undergoing chronic red cell exchange.
    Transfusion. 2023;63:652-655.
    PubMed     Abstract available

  42. ALLISON D, Manon L, Vidanovic V, Crane J, et al
    How do we operate a large monthly red blood cell exchange program.
    Transfusion. 2023;63:450-456.
    PubMed     Abstract available

  43. CROWDER LA, Cable RG, Spencer BR
    Validity of donor-reported iron supplementation practices obtained at the time of donation.
    Transfusion. 2023;63:470-475.
    PubMed     Abstract available

  44. HAJJAJ OI, Cserti-Gazdewich C, Dumevska L, Hanna M, et al
    Reconsidering sickle cell trait testing of red blood cell units allocated to children with sickle cell disease.
    Transfusion. 2023;63:507-514.
    PubMed     Abstract available

    February 2023
  45. DAVIES AT, Devlin PM, Dugan C, Richards T, et al
    Non-erythropoiesis stimulating agent, non-iron therapies for the management of anemia: A scoping review.
    Transfusion. 2023 Feb 22. doi: 10.1111/trf.17274.

  46. DELAFORCE A, Farmer S, Duff J, Munday J, et al
    Results from a type two hybrid-effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway.
    Transfusion. 2023 Feb 21. doi: 10.1111/trf.17287.
    PubMed     Abstract available

  47. GHESQUIERE L, Leroy J, Deken V, Tournier A, et al
    Anti-RH1 alloimmunization: At what maternal antibody threshold is there a risk of severe fetal anemia?
    Transfusion. 2023 Feb 3. doi: 10.1111/trf.17264.
    PubMed     Abstract available

  48. TRAN A, Yan MTS, Branch DR, Blacquiere M, et al
    Severe fetal anemia caused by anti-Jr(a) : Burst forming unit-erythroid colony formation inhibition assay suggesting possible erythroid suppression mechanism.
    Transfusion. 2023 Feb 2. doi: 10.1111/trf.17265.
    PubMed     Abstract available

  49. HE Y, Gao W, Li Y, Xu C, et al
    A single-center, retrospective analysis of 17 cases of hemolytic disease of the fetus and newborn caused by anti-M antibodies.
    Transfusion. 2023 Feb 2. doi: 10.1111/trf.17249.
    PubMed     Abstract available

  50. ALSAGHIR A, Alsaghir L, Alsaif J, Mobeireek A, et al
    Successful therapeutic plasma exchange for a patient with sickle cell disease and fat embolism syndrome after a failure of a response to red cell exchange transfusion.
    Transfusion. 2023;63 Suppl 1:S33-S36.
    PubMed     Abstract available

  51. LENET T, Skanes S, Tropiano J, Verret M, et al
    Patient perspectives on intraoperative blood transfusion: A qualitative interview study with perioperative patients.
    Transfusion. 2023;63:305-314.
    PubMed     Abstract available

    January 2023
  52. JACOBS JW, Abels E, Binns TC, Tormey CA, et al
    Warm autoimmune hemolytic anemia with anti-Jk(a) specificity following babesiosis masquerading as a delayed hemolytic transfusion reaction.
    Transfusion. 2023 Jan 17. doi: 10.1111/trf.17252.
    PubMed     Abstract available

  53. HORNEDO-GONZALEZ KD, Jacob AK, Burt JM, Higgins AA, et al
    Non-invasive hemoglobin estimation for preoperative anemia screening.
    Transfusion. 2023 Jan 5. doi: 10.1111/trf.17237.
    PubMed     Abstract available

    December 2022
  54. RINGEL F, Kiesewetter H, Mayer B, Bartolmas T, et al
    Silvernanoparticle-induced hemolysis confounded with direct antiglobulin test-negative autoimmune hemolytic anemias diagnosis.
    Transfusion. 2022;62:2648-2652.
    PubMed     Abstract available

    November 2022
  55. MAISONNEUVE E, Sohier Lepine M, Maurice P, Pissard S, et al
    Prenatal management of fetal anemia due to pyruvate kinase deficiency: A case report.
    Transfusion. 2022 Nov 8. doi: 10.1111/trf.17177.
    PubMed     Abstract available

    October 2022
  56. KARAFIN MS, Field JJ, Ilich A, Li L, et al
    Hypoxic storage of donor red cells preserves deformability after exposure to plasma from adults with sickle cell disease.
    Transfusion. 2022 Oct 30. doi: 10.1111/trf.17163.
    PubMed     Abstract available

  57. TEAWTRAKUL N, Songdej D, Hantaweepant C, Tantiworawit A, et al
    Red blood cell alloimmunization and other transfusion-related complications in patients with transfusion-dependent thalassemia: A multi-center study in Thailand.
    Transfusion. 2022;62:2039-2047.
    PubMed     Abstract available

  58. ANTHON CT, Granholm A, Sivapalan P, Zellweger N, et al
    Prophylactic platelet transfusions versus no prophylaxis in hospitalized patients with thrombocytopenia: A systematic review with meta-analysis.
    Transfusion. 2022;62:2117-2136.

  59. KRULL A, Thompson T, Strasburg D, DiGuardo M, et al
    How do I warm HPC(A) products to maximize cell viability in the setting of cold agglutinin disease?
    Transfusion. 2022;62:1942-1947.
    PubMed     Abstract available

  60. GERRITSMA JJ, van der Bolt N, van Bruggen R, Ten Brinke A, et al
    Measurement of post-transfusion red blood cell survival kinetics in sickle cell disease and beta-Thalassemia: A biotin label approach.
    Transfusion. 2022;62:1984-1996.
    PubMed     Abstract available

    September 2022
  61. HOPKINS CK, Townsend M, Vassallo RR
    Leukoreduction filters: Still stuck on sickle trait red cells.
    Transfusion. 2022;62:1683-1687.

  62. LAURIDSEN L, Campbell-Lee SA
    Doing more with less: Patient blood management meets sickle cell disease management.
    Transfusion. 2022;62:1688-1692.

  63. GEHRIE EA, Petran L, Young PP
    Sickle cell trait results in a high leukoreduction quality control failure rate for whole blood donations.
    Transfusion. 2022;62:1727-1730.
    PubMed     Abstract available

  64. JONES JM, Swett AD, Crowe EP, Lawrence C, et al
    Implementation of national blood conservation recommendations at an adult sickle cell center.
    Transfusion. 2022;62:1763-1771.
    PubMed     Abstract available

    August 2022
  65. SEHEULT JN, Callum J, Delaney M, Drake R, et al
    Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: The BEST collaborative study.
    Transfusion. 2022;62 Suppl 1:S185-S192.
    PubMed     Abstract available

  66. COVINGTON ML, Cone-Sullivan JK, Andrzejewski C, Lu W, et al
    Unmasking delayed hemolytic transfusion reactions in patients with sickle-cell disease: Challenges and opportunities for improvement.
    Transfusion. 2022;62:1662-1670.

    July 2022
  67. BADE NA, Giri U, Wang H, Ershler WB, et al
    Reduced red cell transfusions and hospitalizations in sickle cell patients treated with voxelotor-Experience from a single center.
    Transfusion. 2022;62:1462-1464.

  68. FUJA C, Kothary V, Carll TC, Singh S, et al
    Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab.
    Transfusion. 2022;62:1446-1451.
    PubMed     Abstract available

  69. HANSEN DL, Moller S, Berentsen S, Frederiksen H, et al
    Mortality in cold agglutinin disease shows seasonal pattern.
    Transfusion. 2022;62:1460-1461.

    June 2022
  70. KRANENBURG FJ, Arbous SM, Caram-Deelder C, Putter H, et al
    Predicting organ functioning with and without blood transfusion in critically ill patients with anemia.
    Transfusion. 2022 Jun 30. doi: 10.1111/trf.16998.
    PubMed     Abstract available

  71. PROCHASKA M, Salcedo J, Berry G, Meltzer D, et al
    Racial differences in red blood cell transfusion in hospitalized patients with anemia.
    Transfusion. 2022 Jun 3. doi: 10.1111/trf.16935.
    PubMed     Abstract available

    May 2022
  72. JOUZIER C, Cherait A, Cony-Makhoul P, Hamel JF, et al
    Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myelodysplasies (GFM).
    Transfusion. 2022;62:961-973.
    PubMed     Abstract available

    April 2022
  73. CARLL T, Mei Z, Aldarweesh F, Wool GD, et al
    Alloimmunization rates in transfused patients receiving anti-CD47 antibody therapy.
    Transfusion. 2022;62:916-918.

    March 2022
  74. GUINN NR, Fuller M, Murray S, Aronson S, et al
    Treatment through a preoperative anemia clinic is associated with a reduction in perioperative red blood cell transfusion in patients undergoing orthopedic and gynecologic surgery.
    Transfusion. 2022 Mar 11. doi: 10.1111/trf.16847.
    PubMed     Abstract available

  75. MEENAN J, Hall R, Badle S, Chatterjee B, et al
    Tocilizumab in the management of posttransfusion hyperhemolysis syndrome in sickle cell disease: The experience so far.
    Transfusion. 2022;62:546-550.
    PubMed     Abstract available

  76. WADE J, Yee MEM, Easley KA, Pahz S, et al
    Procedural adverse events in pediatric patients with sickle cell disease undergoing chronic automated red cell exchange.
    Transfusion. 2022;62:584-593.
    PubMed     Abstract available

  77. YEE ME, Francis RO, Luban NLC, Easley KA, et al
    Glucose-6-phosphate dehydrogenase deficiency is more prevalent in Duffy-null red blood cell transfusion in sickle cell disease.
    Transfusion. 2022;62:551-555.
    PubMed     Abstract available

  78. SEEBER P, Dobel KU, Isbister JP, Murray K, et al
    Mortality and morbidity in non-transfusable and transfusable patients: A systematic review and meta-analysis.
    Transfusion. 2022;62:685-697.

    February 2022
    Commentary on the prescient observations made by Emil J Freireich in Effectiveness of platelet transfusion in leukemia and aplastic anemia (Transfusion 1966; 6: 50-54).
    Transfusion. 2022;62:267-272.

    January 2022
  80. PATRIQUIN CJ, Pavenski K
    O, wind, if winter comes ... will symptoms be far behind?: Exploring the seasonality (or lack thereof) and management of cold agglutinin disease.
    Transfusion. 2022;62:2-10.

  81. ROTH A, Fryzek J, Jiang X, Reichert H, et al
    Complement-mediated hemolysis persists year round in patients with cold agglutinin disease.
    Transfusion. 2022;62:51-59.
    PubMed     Abstract available

  82. KRIGSTEIN M, Cromer N
    Navigating the challenges of Bombay phenotype (Oh ) and twin pregnancy; a case report and literature review.
    Transfusion. 2022;62:247-251.
    PubMed     Abstract available

  83. CARR NR, Henry E, Bahr TM, Ohls RK, et al
    Fetomaternal hemorrhage: Evidence from a multihospital healthcare system that up to 40% of severe cases are missed.
    Transfusion. 2022;62:60-70.
    PubMed     Abstract available

    December 2021
  84. LEE ES, Hendrickson JE, Tormey CA
    RBC alloimmunization and daratumumab: Are efforts to eliminate interferences and prevent new antibodies necessary?
    Transfusion. 2021;61:3283-3285.

  85. KARKI S, Davison TE, Liu B, Bell K, et al
    Visits to general practitioners after iron-related deferrals from blood donation in middle-aged and older Australian blood donors.
    Transfusion. 2021;61:3335-3343.
    PubMed     Abstract available

  86. ARNONI CP, Vendrame T, Muniz J, Cortez A, et al
    RHCE diversity among Brazilian patients with sickle cell disease (SCD) and selected groups of blood donors.
    Transfusion. 2021;61:3473-3482.
    PubMed     Abstract available

    November 2021
  87. DIANA JS, Manceau S, Leblanc T, Magnani A, et al
    A new step in understanding stem cell mobilization in patients with Fanconi anemia: A bridge to gene therapy.
    Transfusion. 2021 Nov 9. doi: 10.1111/trf.16721.
    PubMed     Abstract available

  88. LIOU S, Bakic L, Manakelew B, Guillermo F, et al
    False anemia due to total parenteral nutrition and lipid emulsion contamination.
    Transfusion. 2021 Nov 5. doi: 10.1111/trf.16728.

  89. HAMILTON CM, Davenport DL, Bernard AC
    Demonstration of a U.S. nationwide reduction in transfusion in general surgery and a review of published transfusion reduction methodologies.
    Transfusion. 2021;61:3119-3128.
    PubMed     Abstract available

  90. YAMAMOTO T, Bikhet MH, Marques MB, Nguyen HQ, et al
    Initial experimental experience of triple-knockout pig red blood cells as potential sources for transfusion in alloimmunized patients with sickle cell disease.
    Transfusion. 2021;61:3104-3118.
    PubMed     Abstract available

    October 2021
    Diagnostic algorithm for classification and characterization of direct antiglobulin test-negative autoimmune hemolytic anemia with 1-year clinical follow-up.
    Transfusion. 2021 Oct 19. doi: 10.1111/trf.16709.
    PubMed     Abstract available

  92. CALLAN MB, Thawley VJ, Marryott KA, Shabro A, et al
    Hemolytic anemia blunts the cytokine response to transfusion of older red blood cells in mice and dogs.
    Transfusion. 2021 Oct 11. doi: 10.1111/trf.16690.
    PubMed     Abstract available

  93. TANG CH, Furnback W, Wang BCM, Tang J, et al
    Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta-thalassemia in Taiwan: A real-world analysis.
    Transfusion. 2021;61:2906-2917.
    PubMed     Abstract available

  94. LAL A, Wong T, Keel S, Pagano M, et al
    The transfusion management of beta thalassemia in the United States.
    Transfusion. 2021;61:3027-3039.

  95. ABEL GA, Klepin HD, Magnavita ES, Jaung T, et al
    Peri-transfusion quality-of-life assessment for patients with myelodysplastic syndromes.
    Transfusion. 2021;61:2830-2836.
    PubMed     Abstract available

    September 2021
  96. GADI SRV, Brunker PAR, Al-Samkari H, Sykes DB, et al
    Severe Autoimmune Hemolytic Anemia Following Receipt of SARS-CoV-2 mRNA Vaccine.
    Transfusion. 2021 Sep 22. doi: 10.1111/trf.16672.
    PubMed     Abstract available

  97. ANG AL, Lim CY, Ng WY, Lam JCM, et al
    Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching.
    Transfusion. 2021;61:2566-2577.
    PubMed     Abstract available

  98. AVECILLA ST, Boulad F, Yazdanbakhsh K, Sadelain M, et al
    Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease.
    Transfusion. 2021;61:2775-2781.
    PubMed     Abstract available

    August 2021
  99. TANHEHCO YC, Delgado AC
    Red blood cell reduction of a sickle cell disease stem cell product.
    Transfusion. 2021 Aug 29. doi: 10.1111/trf.16633.

  100. SALINAS CISNEROS G, Webb J, Luban NLC, Nickel RS, et al
    Impact of universal irradiation on chronic transfusion for sickle cell disease.
    Transfusion. 2021;61:2290-2294.
    PubMed     Abstract available

  101. CHIDAMBARAM V, Jones JM, Lokhandwala PM, Bloch EM, et al
    Low rates of transfusion-transmitted infection screening in chronically transfused adults with sickle cell disease.
    Transfusion. 2021;61:2421-2429.
    PubMed     Abstract available

  102. MUNIZ JG, Arnoni C, Medeiros R, Vendrame T, et al
    Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
    Transfusion. 2021;61:2458-2467.
    PubMed     Abstract available

  103. RANKIN A, Darbari D, Campbell A, Webb J, et al
    Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.
    Transfusion. 2021;61:2255-2264.
    PubMed     Abstract available

    July 2021
  104. CAHILL CM, Alhasson B, Blumberg N, Melvin A, et al
    Preoperative anemia management program reduces blood transfusion in elective cardiac surgical patients, improving outcomes and decreasing hospital length of stay.
    Transfusion. 2021 Jul 15. doi: 10.1111/trf.16564.
    PubMed     Abstract available

  105. SARKER TT, Delvadia B, Li S, Roback JD, et al
    Mizuho hemoglobinopathy, presenting with severe hemolytic anemia and multisystem organ failure secondary to exertion.
    Transfusion. 2021 Jul 1. doi: 10.1111/trf.16522.

  106. HASAN RA, Asif M, Tuott EE, Stansbury LG, et al
    Rates of delayed hemolytic transfusion reactions observed in a trauma center.
    Transfusion. 2021;61:2035-2040.
    PubMed     Abstract available

  107. GOWDA L, Vege S, Kessler D, Shaz B, et al
    Screening of blood donors for sickle cell trait using a DNA-based approach: Frequency in a multiethnic donor population.
    Transfusion. 2021;61:2008-2013.
    PubMed     Abstract available

    June 2021
  108. GAMBERINI MR, Fortini M, Stievano A, Calori E, et al
    Impact of the preparation method of red cell concentrates on transfusion indices in thalassemia patients: A randomized crossover clinical trial.
    Transfusion. 2021;61:1729-1739.
    PubMed     Abstract available

  109. GODBEY EA, Anderson MR, M Bachmann L, Sanford KW, et al
    How do we monitor hemoglobin S in patients who undergo red blood cell exchange and take voxelotor?
    Transfusion. 2021;61:1680-1683.

  110. BAROUQA M, Szymanski J, Nelson R, Jofre S, et al
    Bone marrow necrosis and fat embolism syndrome in sickle cell disease: A rapidly deteriorating complication.
    Transfusion. 2021;61:1678-1679.

    May 2021
  111. ANANDAPPA AJ, Stefely JA, Hasserjian RP, Dzik WH, et al
    Multiorgan failure in a fatal case of autoimmune hemolytic anemia.
    Transfusion. 2021 May 27. doi: 10.1111/trf.16513.
    PubMed     Abstract available

  112. LI S, He Z, Mo C, Ji Y, et al
    Hyporegenerative anemia in anti-M-associated hemolytic disease of the fetus.
    Transfusion. 2021 May 3. doi: 10.1111/trf.16350.
    PubMed     Abstract available

  113. MCOMISH C
    A monthly roundup of key articles in other journals.
    Transfusion. 2021;61:1355-1358.

  114. GUARENTE J, Palladino M, Babariya S, Hayes C, et al
    Iatrogenic arteriovenous fistula in patient with sickle cell disease undergoing red blood cell exchange.
    Transfusion. 2021;61:1361-1362.

    April 2021
  115. THEMELIN N, Biston P, Massart J, Lelubre C, et al
    Effects of red blood cell transfusion on global oxygenation in anemic critically ill patients.
    Transfusion. 2021;61:1071-1079.
    PubMed     Abstract available

  116. JUSKEWITCH JE, Murray JD, Norgan AP, Moldenhauer SK, et al
    In from the cold: M-protein light chain glycosylation is positively associated with cold agglutinin titer levels.
    Transfusion. 2021;61:1302-1311.
    PubMed     Abstract available

    March 2021
  117. NGUYEN TN, Maenulein E, Fihman V, Vinatier I, et al
    Serologic characteristics of oxaliplatin antibodies in 15 patients with drug-induced immune hemolytic anemia.
    Transfusion. 2021 Mar 9. doi: 10.1111/trf.16360.
    PubMed     Abstract available

  118. ATAGA KI, Elsherif L, Wichlan D, Wogu AF, et al
    A pilot study of the effect of rivaroxaban in sickle cell anemia.
    Transfusion. 2021 Mar 4. doi: 10.1111/trf.16343.
    PubMed     Abstract available

    February 2021
  119. YATES B, Molloy E, Dulau-Florea A, Braylan R, et al
    Daratumumab for delayed RBC engraftment following major ABO mismatched haploidentical bone marrow transplantation.
    Transfusion. 2021 Feb 2. doi: 10.1111/trf.16281.
    PubMed     Abstract available

  120. DURIEUX-ROUSSEL E, Laget L, Filosa L, Izard C, et al
    RHCE*01 (c.499A>G, p.Met167Val) allele: Weak RhE expression which does not require the E-specific proline 226.
    Transfusion. 2021;61:E18-E20.

  121. ZIEMBA Y, Xu C, Fomani KM, Nandi V, et al
    Safety and benefits of automated red cell depletion-exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion.
    Transfusion. 2021;61:526-536.
    PubMed     Abstract available

  122. DINARDO CL, Oliveira TGM, Kelly S, Ashley-Koch A, et al
    Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed Program.
    Transfusion. 2021;61:603-616.
    PubMed     Abstract available

  123. SLICHTER SJ, Gernsheimer T, LeBlanc R, Townsend-McCall D, et al
    Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia.
    Transfusion. 2021;61:393-403.
    PubMed     Abstract available

    January 2021
  124. ANDERSEN LH, Jacob EK, McThenia SS, Tauscher CD, et al
    Hemolytic disease and reticulocytopenia of the newborn attributable to maternal immunoglobulin G anti-M reacting optimally at cold temperatures.
    Transfusion. 2021 Jan 14. doi: 10.1111/trf.16252.
    PubMed     Abstract available

  125. SPENCER BR, Fox MP, Wise LA, Cable RG, et al
    Iron status and self-reported fatigue in blood donors.
    Transfusion. 2021;61:124-133.
    PubMed     Abstract available

  126. JUSKEWITCH JE, Zuccarelli MD, Berg HE, Summerfield DD, et al
    Transfusion medicine illustrated: When less is more for HLA antibodies.
    Transfusion. 2021;61:9-11.

    Donor iron depletion in context.
    Transfusion. 2021;61:318-321.

  128. RICHARDS AL, Qiu A, Zotti FD, Sheldon K, et al
    Autoantigen presentation by splenic dendritic cells is required for RBC-specific autoimmunity.
    Transfusion. 2021;61:225-235.
    PubMed     Abstract available

  129. SRIVASTAVA K, Albasri J, Alsuhaibani OM, Aljasem HA, et al
    SCAR: The high-prevalence antigen 013.008 in the Scianna blood group system.
    Transfusion. 2021;61:246-254.
    PubMed     Abstract available

  130. SAYERS M
    Donor iron nutrition: Which precaution prevails?
    Transfusion. 2021;61:313-317.

    December 2020
  131. JACOBS J, Eichbaum Q
    COVID-19 associated with severe autoimmune hemolytic anemia.
    Transfusion. 2020 Dec 3. doi: 10.1111/trf.16226.
    PubMed     Abstract available

  132. PAGANO MB, Cataife G, Fertrin KY, Gernsheimer T, et al
    Blood use and transfusion needs at a large health care system in Washington state during the SARS-CoV-2 pandemic.
    Transfusion. 2020;60:2859-2866.
    PubMed     Abstract available

    October 2020
  133. BEVERINA I, Scalvini R, Brando B
    "Camel humps"-shaped red blood cell histogram in a woman with extreme anemia treated with intravenous iron.
    Transfusion. 2020 Oct 28. doi: 10.1111/trf.16154.

  134. GARCIA-GARCIA I, Cid J, Palomino A, Gine E, et al
    Role of therapeutic plasma exchanges in refractory severe warm autoimmune hemolytic anemia: Presentation of two case reports.
    Transfusion. 2020 Oct 22. doi: 10.1111/trf.16143.
    PubMed     Abstract available

  135. STEUER LV, Kondo AT, Cipolletta AN, Sakashita AM, et al
    Predictive factors for the development of anemia after hematopoietic stem cell donation.
    Transfusion. 2020 Oct 14. doi: 10.1111/trf.16124.
    PubMed     Abstract available

  136. MAZZEFFI M, Taneja M, Porter S, Chow JH, et al
    Anemia, sex, and race as predictors of morbidity or mortality after knee arthroplasty surgery.
    Transfusion. 2020 Oct 5. doi: 10.1111/trf.16111.
    PubMed     Abstract available

  137. FERGUSSON DA, Lalu MM
    Mind the evidence gap: The need for trials in the prevention and management of perioperative anemia in noncardiac surgery.
    Transfusion. 2020;60:2168-2170.

    September 2020
  138. SANCHEZ-DURAN MA, Higueras MT, Aviles-Garcia M, Maiz N, et al
    Perinatal outcomes and central nervous system abnormalities following intrauterine fetal transfusion: 17 years' experience in a tertiary center.
    Transfusion. 2020 Sep 21. doi: 10.1111/trf.16087.
    PubMed     Abstract available

  139. NIZZI F, Rees M, Salzberg D, Ngwube A, et al
    Successful management of sirolimus toxicity in a hematopoietic stem cell transplant patient using automated red blood cell exchange.
    Transfusion. 2020 Sep 5. doi: 10.1111/trf.16064.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.